Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGENUS INCAGEN · Entity 5774 | Director | October 03, 2022 | October 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGENUS INC
Report date October 03, 2022 · Filed October 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 239,944.545 |
Reported balance
After 2022-10-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-10-03 · Grant · Acquired 10,102.832 · Balance 239,944.545 F1: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3: $2.598 per Deferred Stock Unit acquired on October 3, 2022. The price of each Deferred Stock Unit acquired on October 3, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.
F2: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.
F3: $2.598 per Deferred Stock Unit acquired on October 3, 2022. The price of each Deferred Stock Unit acquired on October 3, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2022 Filed Oct 5, 2022 17:07 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 10,102.832 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-032917 · doc4.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,944.545 Underlying: Common Stock · 10,102.832 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.598 per Deferred Stock Unit acquired on October 3, 2022. The price of each Deferred Stock Unit acquired on October 3, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 19:52 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 14,192.901 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-025325 · doc4.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,841.713 Underlying: Common Stock · 14,192.901 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $1.85 per Deferred Stock Unit acquired on July 1, 2022. The price of each Deferred Stock Unit acquired prior to July 1, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 22:24 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 9,534.829 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-013868 · doc4.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,648.811 Underlying: Common Stock · 9,534.829 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.753 per Deferred Stock Unit acquired on April 1, 2022. The price of each Deferred Stock Unit acquired prior to April 1, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 23:13 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0000899243-22-005244 · doc4.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-02-04 F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan, as amended, and will vest on February 4, 2023. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 20:25 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 6,547.893 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-000867 · doc4.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,113.982 Underlying: Common Stock · 6,547.893 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $4.009 per Deferred Stock Unit acquired on January 3, 2022. The price of each Deferred Stock Unit acquired prior to January 3, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F2 · derivative.expiration_date: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 23:19 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 4,559.889 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-039314 · doc4.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,566.089 Underlying: Common Stock · 4,559.889 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $5.757 per Deferred Stock Unit acquired on October 1, 2021. The price of each Deferred Stock Unit acquired prior to October 1, 2021 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 21:50 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 6,870.871 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-027295 · doc4.xml · derivative · entry 2 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,006.2 Underlying: Common Stock · 6,870.871 shares Expires not disclosed F2 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F4 · price: $3.820 per Deferred Stock Unit acquired on July 1, 2021. The price of each Deferred Stock Unit acquired prior to July 1, 2021 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F3 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F3 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 15, 2021 Filed Jul 2, 2021 21:50 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0000899243-21-027295 · doc4.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-12-17 F1 · derivative.exercise_date: Option was granted on January 1, 2021, subject to shareholder approval of an increase to the available pool under the Company's 2019 Equity Incentive Plan ("2019 Plan"), which was obtained at the Company's annual shareholder meeting on June 15, 2021. Option awarded in accordance with the 2019 Plan. Option vests in full on December 17, 2022. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:04 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 7,129.658 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-21-000014 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,135.329 Underlying: Common Stock · 7,129.658 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.682 per Deferred Stock Unit acquired on April 1, 2021. The price of each Deferred Stock Unit acquired prior to April 1, 2021 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:43 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 5,620.996 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-21-000005 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,005.671 Underlying: Common Stock · 5,620.996 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.780 per Deferred Stock Unit acquired on January 4, 2021. The price of each Deferred Stock Unit acquired prior to January 4, 2021 is the average of the closing price for the Company's Common Stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's Common Stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's Common Stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 19:34 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to buy) · Derivative | 100,000 | $0.00 Strike: $3.70 | $0.00 |
DisclosureSEC source: 0001745285-20-000050 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-12-17 F1 · derivative.exercise_date: Stock Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The Stock Option vests in full on December 17, 2021 (provided Mr. Jordan continues to serve on the board on such date). Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 18:47 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 5,360.874 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-20-000034 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,384.675 Underlying: Common Stock · 5,360.874 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.964 per Deferred Stock Unit acquired on October 1, 2020. The price of each Deferred Stock Unit acquired prior to October 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 01, 2020 Filed Jul 1, 2020 22:14 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 6,964.314 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-20-000023 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,023.801 Underlying: Common Stock · 6,964.314 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.051 per Deferred Stock Unit acquired on July 1, 2020. The price of each Deferred Stock Unit acquired prior to July 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 21:34 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to buy) · Derivative | 2,500 | $0.00 Strike: $3.56 | $0.00 |
DisclosureSEC source: 0001745285-20-000016 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2030-06-16 F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan and will vest on June 16, 2021. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 18:17 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 6,641.629 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-20-000001 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,059.487 Underlying: Common Stock · 6,641.629 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.200 per Deferred Stock Unit acquired on April 1, 2020. The price of each Deferred Stock Unit acquired prior to April 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:14 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 5,850.359 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-000512 · doc4.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,417.858 Underlying: Common Stock · 5,850.359 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.419 per Deferred Stock Unit acquired on January 2, 2020. The price of each Deferred Stock Unit acquired prior to January 2, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| December 24, 2019 Filed Dec 27, 2019 20:34 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to buy) · Derivative | 75,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000899243-19-030102 · doc4.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-12-24 F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan and will vest on December 24, 2020. Read SEC document |
| October 01, 2019 Filed Oct 1, 2019 18:44 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 7,336.505 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-19-000013 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,567.499 Underlying: Common Stock · 7,336.505 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.726 per Deferred Stock Unit acquired on October 1, 2019. The price of each Deferred Stock Unit acquired prior to October 1, 2019 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 10:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 7,185.629 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-018766 · doc4.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,230.994 Underlying: Common Stock · 7,185.629 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.783 per Deferred Stock Unit acquired on July 1, 2019. The price of each Deferred Stock Unit acquired prior to July 1, 2019 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Units were acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 21:16 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option, Right to buy · Derivative | 100,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0000899243-19-017822 · doc4.xml · derivative · entry 2 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,500 Underlying: Common Stock · 100,000 shares Expires 2029-01-01 F1 · derivative.exercise_date: Option was granted on January 1, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan. The option vests on January 1, 2020. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 21:16 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option, Right to buy · Derivative | 2,500 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0000899243-19-017822 · doc4.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2029-01-01 F1 · derivative.exercise_date: Option was granted on January 1, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan. The option vests on January 1, 2020. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 18:38 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 6,327.144 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-19-000004 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,045.366 Underlying: Common Stock · 6,327.144 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.161 per Deferred Stock Unit acquired on April 1, 2019. The price of each Deferred Stock Unit acquired prior to April 1, 2019 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Units were acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:43 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Shares · Derivative | 8,234.987 | $2.13 Strike: $2.13 | $17,499.35 |
DisclosureSEC source: 0001745285-19-000001 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,234.987 Underlying: Common Stock · 8,234.987 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 19:26 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Shares · Derivative | 8,727.834 | $2.01 Strike: $2.01 | $17,499.31 |
DisclosureSEC source: 0001288123-18-000024 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,727.834 Underlying: Common Stock · 8,727.834 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 02, 2018 Filed Jul 2, 2018 19:21 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Shares · Derivative | 5,095.773 | $3.43 Strike: $3.43 | $17,498.88 |
DisclosureSEC source: 0001288123-18-000019 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,095.773 Underlying: Common Stock · 5,095.773 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 16:04 UTC | AGENUS INC AGEN · Entity 5774 | GrantCommon Stock · Derivative | 37,500 | $5.65 Strike: $5.65 | $211,875.00 |
DisclosureSEC source: 0001288123-18-000013 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2028-03-02 F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, vesting on March 2, 2019. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 20:14 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Shares · Derivative | 3,866.633 | $4.53 Strike: $4.53 | $17,500.38 |
DisclosureSEC source: 0000899243-18-009228 · doc4.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,866.633 Underlying: Common Stock · 3,866.633 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:04 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Shares · Derivative | 4,500.367 | $3.89 Strike: $3.89 | $17,501.93 |
DisclosureSEC source: 0001288123-18-000001 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500.367 Underlying: Common Stock · 4,500.367 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 02, 2018 Filed Jan 19, 2018 21:16 UTC Amendment | AGENUS INC AGEN · Entity 5774 | GrantDeferred Shares · Derivative | 5,271.859 | $3.89 Strike: $3.89 | $20,502.26 |
DisclosureSEC source: 0001288123-18-000004 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,271.859 Underlying: Common Stock · 5,271.859 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 21:23 UTC | AGENUS INC agen · Entity 5774 | GrantDeferred Shares · Derivative | 4,242.093 | $4.13 Strike: $4.13 | $17,498.63 |
DisclosureSEC source: 0001288123-17-000034 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,242.093 Underlying: Common Stock · 4,242.093 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 30, 2017 Filed Jul 3, 2017 15:08 UTC | AGENUS INC agen · Entity 5774 | GrantDeferred Shares · Derivative | 4,186.603 | $3.58 Strike: $3.58 | $15,000.60 |
DisclosureSEC source: 0001288123-17-000026 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,186.603 Underlying: Common Stock · 4,186.603 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 15:08 UTC | AGENUS INC agen · Entity 5774 | GrantStock Optoin, Right to buy · Derivative | 2,500 | $3.91 Strike: $3.91 | $9,775.00 |
DisclosureSEC source: 0001288123-17-000026 · primary_doc.xml · derivative · entry 3 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2027-06-29 F3 · derivative.exercise_date: Option vests 100% on the one-year anniversary of the grant date. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 15:08 UTC | AGENUS INC agen · Entity 5774 | GrantStock Option, Right to buy · Derivative | 50,000 | $3.91 Strike: $3.91 | $195,500.00 |
DisclosureSEC source: 0001288123-17-000026 · primary_doc.xml · derivative · entry 2 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-06-29 F2 · derivative.exercise_date: Annual option award vesting 100% on the earlier of the one-year anniversary of the grant date or the date of the Company's 2018 annual shareholder meeting. Read SEC document |
| April 03, 2017 Filed Apr 6, 2017 20:29 UTC | AGENUS INC agen · Entity 5774 | GrantDeferred Shares · Derivative | 3,715.69 | $4.04 Strike: $4.04 | $15,000.24 |
DisclosureSEC source: 0001288123-17-000018 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,715.69 Underlying: Common Stock · 3,715.69 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| March 08, 2017 Filed Mar 20, 2017 23:24 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option, Right to Buy · Derivative | 8,800 | $3.97 Strike: $3.97 | $34,936.00 |
DisclosureSEC source: 0001288123-17-000007 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,800 Underlying: Common Stock · 8,800 shares Expires 2027-03-08 F1 · derivative.exercise_date: 100% of options vest on one-year anniversary of the grant date. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 01:22 UTC | AGENUS INC agen · Entity 5774 | GrantDeferred Shares · Derivative | 2,998.287 | $5.00 Strike: $5.00 | $15,000.43 |
DisclosureSEC source: 0001288123-17-000001 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,998.287 Underlying: Common Stock · 2,998.287 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:17 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Shares · Derivative | 2,567.944 | $5.84 Strike: $5.84 | $14,999.36 |
DisclosureSEC source: 0001288123-16-000094 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,567.944 Underlying: Common Shares · 2,567.944 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed with the terms of the Plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed with the terms of the Plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed with the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.